porphobilinogen has been researched along with valproic acid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adamson, AR; Brodie, MJ; Goldberg, A; Herrick, AL; McColl, KE; Moore, MR | 1 |
Brodie, MJ; Macphee, GJ; McGuire, GM; Moore, MR; Thompson, GG | 1 |
Bonkowsky, HL; Emery, S; Sinclair, JF; Sinclair, PR | 1 |
1 trial(s) available for porphobilinogen and valproic acid
Article | Year |
---|---|
Effects of sodium valproate on haem biosynthesis in man: implications for seizure management in the porphyric patient.
Topics: 5-Aminolevulinate Synthetase; Adolescent; Adult; Drug Administration Schedule; Epilepsy; Female; Heme; Humans; Male; Middle Aged; Porphobilinogen; Porphyrias; Porphyrins; Valproic Acid | 1988 |
2 other study(ies) available for porphobilinogen and valproic acid
Article | Year |
---|---|
Acute intermittent porphyria in two patients on anticonvulsant therapy and with normal erythrocyte porphobilinogen deaminase activity.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Ammonia-Lyases; Anticonvulsants; Erythrocytes; Female; Humans; Hydroxymethylbilane Synthase; Male; Middle Aged; Phenytoin; Porphobilinogen; Porphyrias; Valproic Acid | 1989 |
Seizure management in acute hepatic porphyria: risks of valproate and clonazepam.
Topics: 5-Aminolevulinate Synthetase; Adult; Aminolevulinic Acid; Animals; Benzodiazepinones; Chick Embryo; Clonazepam; Cytochrome P-450 Enzyme System; Hemin; Humans; Liver Diseases; Male; Porphobilinogen; Porphyrias; Rats; Seizures; Valproic Acid | 1980 |